Non-Invasive Prenatal Testing Market Growth Opportunities Across Healthcare and Diagnostics 2030

Noninvasive prenatal testing/ screening (NIPT/NIPS) measures fetal genetic abnormalities by analyzing cell-free DNA (cfDNA) in a pregnant woman's blood.

Non-Invasive Prenatal Testing Market Growth Opportunities Across Healthcare and Diagnostics 2030

Non-Invasive Prenatal Testing Market Overview

The Non-Invasive Prenatal Testing Market report provides an in-depth analysis that is required to make informed industry decisions and develop strategic growth plans. Regardless of the production method or cost structures, the Non-Invasive Prenatal Testing market report provides a full understanding of advanced tactics and plans. 

The Non-Invasive Prenatal Testing Market size was valued at USD 5.12 Billion in 2023 and the total Non-Invasive Prenatal Testing revenue is expected to grow at a CAGR of 10.08% from 2024 to 2030, reaching nearly USD 10.03 Billion by 2030.

For further information, click the following link:https://www.maximizemarketresearch.com/request-sample/32130/

Non-Invasive Prenatal Testing Market Report Scope and Research Methodology

The report offers an extensive examination of top players' strategies within the Non-Invasive Prenatal Testing industry, coupled with an in-depth analysis of market segments and regional dynamics. In-depth insights into market dynamics, encompassing drivers, restraints, opportunities, and challenges, are provided both on a regional and segmental basis within the Non-Invasive Prenatal Testing Market report. Additionally, the report presents import/export consumption, supply and demand, pricing, costs, revenue, and gross margins data, serving as an invaluable guide for investors.

The data for the Non-Invasive Prenatal Testing Market report was meticulously gathered through a combination of primary and secondary research methods, ensuring its authenticity. Primary research methods employed encompassed questionnaire distribution, surveys, and phone interviews with Non-Invasive Prenatal Testing industry experts, market leaders, marketing professionals, and entrepreneurs. The report's estimations of global and regional Non-Invasive Prenatal Testing market size were derived using a bottom-up approach. Furthermore, the strengths and weaknesses of Non-Invasive Prenatal Testing key players within the industry are outlined using SWOT analysis.

Non-Invasive Prenatal Testing Market Regional Insights

The report delves into the Non-Invasive Prenatal Testing business in great depth, segmenting it into numerous locations. North America, South America, Europe, Asia Pacific (APAC), Africa, and the Middle East are evaluated by region and country in the study. In the Non-Invasive Prenatal Testing market report, regional markets are thoroughly investigated in order to uncover regional market trends, restrictions, and possible prospects.

Non-Invasive Prenatal Testing Market Segmentation

By Gestation Period

0-12 Weeks
13-24 Weeks
25-36 Weeks

By Pregnancy Risk

High & Average Risk
Low Risk

By Method

Ultrasound Detection
Biochemical Screening Tests
Cell-free DNA in Maternal Plasma Tests

By Technology

NGS
Array Technology
PCR
Others

By Product

Consumables & Reagents
Instruments

By Application

Trisomy
Microdeletion Syndrome
Other Applications

By End-User

Hospitals
Diagnostic Laboratories
Others

For further information, click the following link:https://www.maximizemarketresearch.com/request-sample/32130/

Non-Invasive Prenatal Testing Market Key Players

Leading Non-invasive prenatal testing services providers in the North America:
1. Laboratory Corporation of America Holdings (LabCorp) - (Carolina, USA)
2. Agilent Technologies, Inc. - (California, USA)
3. Thermo Fisher Scientific Inc. - (Massachusetts, USA)
4. GE Healthcare - (Chicago, Illinois, USA; part of General Electric Company)
5. Progenity, Inc. - (San Diego, California, USA)
6. Genesis Genetics (CooperSurgical, Inc.) - (Livingston, New Jersey, USA)
7. Natera, Inc. - (San Carlos, California, USA)
8. Illumina, Inc. (Verinata Health, Inc.) - (San Diego, California, USA)
9. Myriad Women’s Health, Inc. (Counsyl, Inc.) - (South San Francisco, California, USA)
10. Quest Diagnostics, Inc. - (Secaucus, New Jersey, USA)

Major non-prenatal testing solution providers in Europe:
1. Eurofins LifeCodexx AG - (Konstanz, Germany)
2. Yourgene Health - (Manchester, United Kingdom)
3. Centogene N.V. - (Rostock, Germany)
4. F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) - (Basel, Switzerland)
5. IGENOMIX - (Valencia, Spain)
6. Qiagen - (Venlo, Netherlands)

List of non-invasive prenatal testing services providers in Asia:
1. BGI (Beijing Genomics Institute) - (Shenzhen, China)
2. MedGenome Labs Ltd. - (Bangalore, India)
3. Eisai (Japan)
4. Nihon Gene Research Laboratories (NGRL) (Japan)
5. Seegene (South Korea)
6. Genetic Diagnostics Singapore (GDS) (Singapore)

Key Offerings:

    • A detailed Market Overview
    • Market Share, Size & Forecast by Revenue 
    • Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Key Trends
    • Market Segmentation – A detailed analysis by segments and sub-segments 
    • Regional Insights
    • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

 Trending Reports:

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

[email protected] 

+91 96071 95908, +91 9607365656